Author:
Du Xin, ,Zheng Yang,Yang Ping,Ma Shuren,Yu Zaixin,Su Xi,Ge Junbo,Leonsson-Zachrisson Maria,Wang Xianhong,Sun Jing,Bai Lu,Ma Chang-Sheng
Funder
AstraZeneca Investment (China) Co.Ltd
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference24 articles.
1. National Center for Cardiovascular Diseases, China. Report on cardiovascular diseases in China 2017 [in Chinese]. http://www.nccd.org.cn/Sites/Uploaded/File/2018/5/中国心血管病报告2017%EF%BC%88中文版%EF%BC%89.pdf. Accessed 21 Jun 2018.
2. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15(2 suppl):S36–41.
3. Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2011;8(3):140–7.
4. Gao R, Patel A, Gao W, CPACS Investigators, et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 2008;94(5):554–60.
5. Huo Y, Han Y, Ge J, et al. Two-year outcomes post discharge in Chinese patients with acute coronary syndrome: findings from the EPICOR Asia study. J Am Coll Cardiol. 2016;67(13):505.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献